Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002948421 | SCV003274901 | likely benign | not provided | 2024-01-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004067985 | SCV003715941 | uncertain significance | not specified | 2021-12-03 | criteria provided, single submitter | clinical testing | The c.6974A>G (p.N2325S) alteration is located in exon 9 (coding exon 9) of the FAT2 gene. This alteration results from a A to G substitution at nucleotide position 6974, causing the asparagine (N) at amino acid position 2325 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV002948421 | SCV004157459 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | FAT2: BP4, BS1 |